1. Home
  2. MYGN vs MSGE Comparison

MYGN vs MSGE Comparison

Compare MYGN & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$7.02

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Logo Madison Square Garden Entertainment Corp.

MSGE

Madison Square Garden Entertainment Corp.

HOLD

Current Price

$52.83

Market Cap

2.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
MSGE
Founded
1991
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
625.5M
2.3B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MYGN
MSGE
Price
$7.02
$52.83
Analyst Decision
Buy
Buy
Analyst Count
12
6
Target Price
$11.82
$53.67
AVG Volume (30 Days)
1.1M
329.5K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
$825,300,000.00
$962,282,000.00
Revenue This Year
$0.10
$9.36
Revenue Next Year
$5.28
$5.33
P/E Ratio
N/A
$76.01
Revenue Growth
0.21
0.68
52 Week Low
$3.76
$28.29
52 Week High
$15.47
$55.75

Technical Indicators

Market Signals
Indicator
MYGN
MSGE
Relative Strength Index (RSI) 46.64 62.06
Support Level $7.15 $48.66
Resistance Level $7.43 $55.75
Average True Range (ATR) 0.30 1.54
MACD -0.00 0.27
Stochastic Oscillator 11.44 64.65

Price Performance

Historical Comparison
MYGN
MSGE

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Share on Social Networks: